期刊文献+

特应性皮炎患者RANTES、MIP-1α及趋化因子受体CCR5测定及其意义 被引量:2

Detection of regulated on activation normal T cell expressed and secreted,macrophage inflammatory protein-1 alpha and chemokine receptor CCR5 in patients with atopic dermatitis
下载PDF
导出
摘要 目的探讨调节正常T细胞表达和分泌活性因子(Regulated on activation normal T cell expressed and secre-ted,RANTES),巨噬细胞炎性蛋白(Macrophage inflammatory protein-1,MIP-1α)及趋化因子受体CCR5在特应性皮炎(AD)发病中的作用。方法采集30例AD患者及10例健康对照者血液,分离血清和外周血单个核细胞(PBMC),双抗体夹心ELISA法检测PBMC产生的RANTES、MIP-1α含量,荧光定量PCR检测外周血PBMC表达的CCR5 mRNA水平。结果特应性皮炎患者与健康对照者血清RANTES含量分别为(55.7±3.4)μg/L和(35.6±1.8)μg/L,差异有显著性(t=3.036,P<0.01),且RANTES水平与SCORAD呈正相关(r=0.889,P<0.05);MIP-1α含量分别为(51.8±3.6)μg/L和(44.7±4.3)μg/L,差异有显著性(t=2.465,P<0.05)。CCR5 AD患者为1.284±0.088,健康对照为1.133±0.075,差异有显著性(t=2.752,P<0.05)。结论RANTES和MIP-1α及特异性受体CCR5在特应性皮炎患者中均显著增高,差异有显著性,在AD的发病中可能起重要作用。 Objective To explore the roles of regulated on activation normal T cell expressed and secreted (RANTES), macrophage inflammatory protein-1 alpha(MIP-1α)and chemokine receptor CCR5 in the pathogenesis of atopic dermatitis. Methods 30 atopic dermatitis and 10 normal controls were collected. Pt3MC were separated from the peripheral blood specimen. ELISA method was used to determine the concentration of RANTES and MIP-1α levels in serum. QRT-PCR was used to detect the expression of CCR5 mRNA in PBMC. Results RANTES and MIP-1α were both higher in patients than that of normal controls (P〈0.01 ,P〈0.05). Furthermore, there was a significant positive correlation between disease activity and RANTES levels(r=0.889, P〈0.05). Level of CCR5 mR NA expression was significantly increased in patients than in controls(P〈0.05). Conclusion Our findings indicate that RANTES, MIP-1α and CCR5 may be involved in the pathogenesis of AD, and the expression level may be a good indicator for the disease activity of AD.
出处 《中国病原生物学杂志》 CSCD 2007年第2期101-103,共3页 Journal of Pathogen Biology
关键词 特应性皮炎 RANTES MIP-1 αCCR5 Atopic dermatitis RANTES MIP-1α CCR5
  • 相关文献

参考文献5

二级参考文献12

  • 1Lim S, John M, Seybold J, et al. Increased interleukin-10 and macrophage inflammatory protein-1 alpha release from blood monocytes ex vivo during late-phase response to allergen in asthma[J]. Allergy, 2000, 55(5): 489-495.
  • 2Cruikshank WW, Long A, Tarpy RE, et al. Early identification of interleukin-16 (lymphocyte chemoattratant factor) and macrophage inflammatory protein-1 alpha(MIP-1 alpha) in bronchoalveolar lavage fluid of antigen-challenged asthmatics [J]. Am J Respir Cell Mol Bio1,1995,13 (6) : 738-747.
  • 3Alam R, York J, Boyars M, et al. Increased MCP-1, RASTES, and MIP-1 alpha in bronchoalveolar lavage flaid of allergic[J].Am J gespir Crit Care Med, 1996,153(4 Pt 1)-1398-1404.
  • 4Taub DD, Conlon K, Lloyd AR, et al. Preferential migration of activated CD4+ anti CD8+ T cells in response to MIP-lα and MIP-1B [J].Science, 1993, 260(5106):355-358.
  • 5Tillie-Leblond I, Hammand H, Desurmont S, et al. CC chemonkines and interlGukin-5 in bronchoalveolar lavage fluid from patients with status asthmathicus. Potential implication in eosinophil recruitment[J]. Am J RGspir Grit Care Med, 2000,162(2 Pt 1):586-592.
  • 6Kurashima K, Mukaida N, Fujimura M, et al. Increase of chemokine levels in sputunm precedes exacerbation of acute asthma attacks[J]. J Leukoc Biol, 1996, 59(3):313-316.
  • 7Virchow JC, Holscher W, Virchow C. Sputum ECP levels correlate with paramctcrs of airflow obstruction. Am Rev Respir Dis, 1992,146:604-606.
  • 8John M, Lim S, Seybold J, et al. Inhaled Corticosteroids increase interleukin-lO but reduce macrophage inflamatory protein-1 alpha, granulocyte-macrophage colony-stimulating factor, and interferongamma release from alveolar macrophages in asthma[J]. Am J Respir crit Care Med, 1998,157(1):256-262.
  • 9Eva Fernvik,Joachim Lundahl,Gunilla Halldén. The Impact of Eotaxin- and IL-5-Induced Adhesion and Transmigration on Eosinophil Activity Markers[J] 2000,Inflammation(1):73~87
  • 10支气管哮喘防治指南[J].中华结核和呼吸杂志,1997,20(5):261-267. 被引量:2007

共引文献6

同被引文献22

  • 1肖国生,曹三杰,文心田.荧光定量PCR技术及其在动物传染病定量检测中的应用[J].动物医学进展,2005,26(2):13-17. 被引量:18
  • 2吴江,曾仁山.异位性皮炎患者外周血Th2细胞分化偏态性分析[J].中国麻风皮肤病杂志,2005,21(8):616-617. 被引量:6
  • 3Oyoshi MK,He R,Kumar L,et al.Cellular and molecular mechanisms in atopic dermatitis[J].Adv Immunol,2009,102:135-226.
  • 4Hanifin JM.Chan S.Biochemical and immunologic mechanisms in atopic dermatitis:new targets for emerging therapies[J].J Am Acad Dermalol,1999.41:72-77.
  • 5Leung DY.Atopic dermatitis:new insights and opportunities for therapeutic intervention[J].J Allergy Clin Immunol,2000,105:860-876.
  • 6Kato Y,Pawunkar R,Kimura Y,et al.Increased expression of RANTES.CCR3 and CCR5 in the lesional skin of patients with atopic eczema[J].Int Arch Allergy Immunol,2006,139:245-257.
  • 7Hanifin JM.Rajka G.Diagnostic features of atopic dermatitis[J].Arch Dermatol Venerol (Stockh),1980,92:44-47.
  • 8Kunz B,Oranje AP,Labreze L,et al.Clinical validation and guidelines for the SCOKAD index:consensus report of the European Task Force on Atopic Dermalitis[J].Dermatol.l997,195:10-19.
  • 9Bonecchi R,Galliera E,Borroni EM.et al.Chemokines and chemokine receptors:an overview[J].Front Biosci,2009,14:540-551.
  • 10Zlotnik A,Yoshie O.Chemokines:a new classification system and their role in immunity[J].Immunity,2000,12:121-7.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部